Aclaris Therapeutics Inc. (ACRS) on Thursday reported a loss of $27.6 million in its fourth quarter
WAYNE, Pa. (AP) — WAYNE, Pa. (AP) — Aclaris Therapeutics Inc. (ACRS) on Thursday reported a loss of $27.6 million in its fourth quarter.
The Wayne, Pennsylvania-based company said it had a loss of 41 cents per share.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 46 cents per share.
The specialty pharmaceutical company posted revenue of $7.8 million in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $2.2 million.
For the year, the company reported that its loss narrowed to $86.9 million, or $1.33 per share. Revenue was reported as $29.8 million.
Aclaris shares have decreased 19% since the beginning of the year. The stock has declined slightly more than 5% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a ACRS">Zacks stock report on ACRS at https://www.zacks.com/ap/ACRS